Advanced Enzymes Q1 FY27 net profit fell 7.5% to ₹37 crore, revenue rose 2.2% to ₹190 crore. EBITDA declined 9.6%. Board approved share buyback and acquisition of remaining JC Biotech stake.
Advanced Enzymes Q1 FY27 net profit fell 7.5% to ₹37 crore, revenue rose 2.2% to ₹190 crore. EBITDA declined 9.6%. Board approved share buyback and acquisition of remaining JC Biotech stake.